CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
High ImpactOriginal article

Biohaven’s epilepsy drug hit with FDA clinical hold

RegulatoryNegative
AI Analysis

Summary

Biohaven's epilepsy drug has been placed under FDA clinical hold, representing a significant regulatory setback for the company's development program.

Outcome Details

FDA clinical hold on epilepsy drug

Importance:8/10
Sentiment:
-0.90
FDAclinical holdepilepsyregulatory setback
Related Companies

Read the original article

Published by yahoo_finance on September 11, 2026 11:17 AM

Read Original